Research output per year
Research output per year
Fingerprint
Dive into the research topics where Kris Van Moer is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Epithelial to mesenchymal transition regulates surface pd-l1 via cmtm6 and cmtm7 induction in breast cancer
Xiao, M., Hasmim, M., Lequeux, A., Van Moer, K., Tan, T. Z., Gilles, C., Hollier, B. G., Thiery, J. P., Berchem, G., Janji, B. & Noman, M. Z., 9 Mar 2021, In: Cancers. 13, 5, p. 1-12 12 p., 1165.Research output: Contribution to journal › Article › Research › peer-review
Open Access9 Citations (Scopus) -
Targeting HIF-1 alpha transcriptional activity drives cytotoxic immune effector cells into melanoma and improves combination immunotherapy
Lequeux, A., Noman, M. Z., Xiao, M., Van Moer, K., Hasmim, M., Benoit, A., Bosseler, M., Viry, E., Arakelian, T., Berchem, G., Chouaib, S. & Janji, B., 15 Jul 2021, In: Oncogene. 40, 28, p. 4725-4735 11 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access21 Citations (Scopus) -
Inhibition of Vps34 reprograms cold into hot inflamed tumors and improves anti-PD-1/PD-L1 immunotherapy
Noman, M. Z., Parpal, S., van Moer, K., Xiao, M., Yu, Y., Viklund, J., de Milito, A., Hasmim, M., Andersson, M., Amaravadi, R. K., Martinsson, J., Berchem, G. & Janji, B., Apr 2020, In: Science advances. 6, 18, eaax7881.Research output: Contribution to journal › Article › Research › peer-review
Open Access74 Citations (Scopus) -
Impact of hypoxic tumor microenvironment and tumor cell plasticity on the expression of immune checkpoints
Lequeux, A., Noman, M. Z., Xiao, M., Sauvage, D., Van Moer, K., Viry, E., Bocci, I., Hasmim, M., Bosseler, M., Berchem, G. & Janji, B., 28 Aug 2019, In: Cancer Letters. 458, p. 13-20 8 p.Research output: Contribution to journal › Review article › peer-review
Open Access57 Citations (Scopus) -
CD47 is a direct target of SNAI1 and ZEB1 and its blockade activates the phagocytosis of breast cancer cells undergoing EMT
Noman, M. Z., Van Moer, K., Marani, V., Gemmill, R. M., Tranchevent, L. C., Azuaje, F., Muller, A., Chouaib, S., Thiery, J. P., Berchem, G. & Janji, B., 3 Apr 2018, In: OncoImmunology. 7, 4, e1345415.Research output: Contribution to journal › Article › Research › peer-review
Open Access43 Citations (Scopus)